Non-Invasive Ventilation in COPD
A 72-year-old man with chronic obstructive pulmonary disease presents with increasing dyspnoea and purulent sputum. He is drowsy but rousable and follows commands, with no vomiting and an intact cough. Oxygen saturation is 94 percent on 4 L/min. After an hour of nebulised bronchodilators, corticosteroids, and antibiotics, arterial blood gas shows pH 7.26 and PaCO2 72 mm Hg. Which of the following is the most appropriate next step in management?
- A.Proceed directly to intubation and invasive ventilation
- B.Increase oxygen delivery to 10 L/min by face mask
- C.Give an intravenous bolus of doxapram infusion
- D.Begin a trial of bilevel non-invasive ventilationCorrect
Explanation
Acute-on-chronic hypercapnic respiratory failure in a COPD exacerbation, defined by pH below 7.35 with a raised PaCO2 persisting after 1 hour of optimal bronchodilator, corticosteroid, and antibiotic therapy, is the strongest evidence-based indication for bilevel non-invasive ventilation. The elevated bicarbonate of 32 mmol/L confirms chronic carbon dioxide retention with an acute decompensation superimposed. Inspiratory positive airway pressure augments tidal volume and offloads fatigued respiratory muscles, while expiratory positive airway pressure counteracts intrinsic PEEP and reduces the work of triggering, and together they lower PaCO2, correct the acidosis, and cut intubation rates and mortality. Mild drowsiness caused by hypercapnia is not by itself a contraindication provided the patient is rousable, cooperative, and able to protect the airway, as here, and such patients often improve rapidly on non-invasive ventilation. Increasing oxygen flow is harmful because saturation is already 94 percent, above the 88 to 92 percent target for COPD, and further oxygen worsens hypercapnia through increased dead space from released hypoxic pulmonary vasoconstriction and the Haldane effect. Doxapram is an obsolete respiratory stimulant with a narrow therapeutic index that has been superseded by non-invasive ventilation. Immediate intubation is reserved for respiratory arrest, cardiovascular instability, inability to protect the airway, copious secretions, or failure of a non-invasive ventilation trial, so it should follow rather than replace non-invasive ventilation here. Arterial blood gas must be repeated 1 hour after starting to confirm response.
Why each option
- A.
- Intubation is reserved for failure of non-invasive ventilation, respiratory arrest, haemodynamic instability, or inability to protect the airway.
- B.
- Saturation of 94 percent already exceeds the 88 to 92 percent COPD target, and more oxygen would worsen carbon dioxide retention and acidosis.
- C.
- Doxapram is an obsolete respiratory stimulant with a narrow therapeutic index that has been replaced by non-invasive ventilation.
- D.
- Correct. Persisting respiratory acidosis with hypercapnia after optimal medical therapy in a rousable, airway-protecting COPD patient is the classic indication for non-invasive ventilation.
Reference: GOLD Report: Global Strategy for the Diagnosis, Management and Prevention of COPD, 2024; ERS/ATS Guidelines on Noninvasive Ventilation for Acute Respiratory Failure, 2017
This is one of 3,009 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank